SCFAs inhibit the NF–κB pathway and reduce the production of pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α, which can alleviate skin symptoms in psoriasis, acne, or HS (169). Here, IL6 is linked to psoriasis.